Occupational Diseases  >>  Hetlioz (tasimelteon)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Hetlioz (tasimelteon) / Vanda
NCT02130999: Open Label Study to Assess the Absolute Bioavailability of Tasimelteon (HETLIOZ™)

Completed
4
14
US
tasimelteon 20 mg capsule, Hetlioz™ 20 mg, tasimelteon 2 mg I.V.
Vanda Pharmaceuticals
Non-24-Hour-Sleep-Wake Disorder
05/14
05/14

Download Options